renal

Renal Care Group erhält Vorlageverfügung zum ehemaligen Aktienoptionsprogramm

02.06.2006, 10:16, Company-Internal, Fresenius AG (SE)

Fresenius Medical Care erwirbt Renal Solutions, Inc.

29.11.2007, 08:24, Cooperations / Mergers, Fresenius AG (SE)

Fresenius Medical Care übernimmt das US-amerikanische Unternehmen Renal Solutions, Inc. (RSI). Mit der Akquisition von RSI erwirbt Fresenius Medical Care eine wesentliche...

Fresenius Medical Care schließt Übernahme der Renal Care Group ab

31.03.2006, 17:12, Cooperations / Mergers, Fresenius AG (SE)

Fresenius Medical Care schließt den Verkauf von Dialysekliniken im Zusammenhang mit der Übernahme der Renal Care Group ab

10.04.2006, 08:58, Medical Technology, Fresenius AG (SE)

Read more

LipoNova Got General Approval from FDA for The Overall Development Program of The Autologous Tumor Vaccine in Renal Cancer

18.09.2007, 16:51, Research / Development, LipoNova AG

LipoNova AG (WKN LNAG00) the pioneering developer of Reniale(R), the world’s first autologous vaccine for renal cell carcinoma (RCC) has been given the go-ahead...

Read more

Speedel retains all development & commercialisation Rights to SPP200

16.08.2006, 09:48, Company-Internal, Speedel Pharma AG

WILEX successfully completes Phase II study with RENCAREX®* in combination with Interferon

16.10.2006, 16:25, Research / Development, Wilex AG

Read more

Fresenius Medical Care Acquires Renal Solutions, Inc.

29.11.2007, 08:29, Cooperations / Mergers, Fresenius AG (SE)

Fresenius Medical Care AG & Co. KGaA today announced that it has acquired Renal Solutions, Inc. (RSI). The acquisition agreement provides for total consideration...

Fresenius Medical Care Reports Strong Third Quarter and Nine Months Results; Confirms Outlook for 2008

04.11.2008, 10:15, Finances / Balance sheet, Fresenius AG (SE)

Fresenius Medical Care AG & Co. KGaA ("the Company"), the world's largest provider of Dialysis Products and Services, today announced its results for the third quarter...

Read more

Roche NimbleGen CGH Arrays Enable Detection of the Genomic Disorder Resulting in Diabetes

01.08.2008, 18:12, Biotechnology, Roche Diagnostics GmbH

Chromosomal rearrangements leading to genomic disorders are often mediated by low-copy repeat regions of the genome (e.g. segmental duplications). Roche NimbleGen...

Read more